[Early treatment of sexual exposure to human immunodeficiency virus].
Derancourt
C
C
Service de Dermatologie, Hôpital Robert Debré, avenue du Général-Koenig, 51092 Reims Cedex.
Drobacheff
C
C
Verraes
S
S
Beguinot
I
I
Bernard
P
P
D000163:Acquired Immunodeficiency Syndrome / Q000517:prevention & control; D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D004338:Drug Combinations; D005260:Female; D015658:HIV Infections / Q000517:prevention & control* / Q000635:transmission; D017320:HIV Protease Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use; D006801:Humans; D019259:Lamivudine / Q000627:therapeutic use; D008297:Male; D019888:Nelfinavir / Q000627:therapeutic use; D011336:Probability; D012307:Risk Factors; D012725:Sexual Behavior; D012747:Sexual Partners; D013997:Time Factors; D015215:Zidovudine / Q000627:therapeutic use
D019380:Anti-HIV Agents; D004338:Drug Combinations; D017320:HIV Protease Inhibitors; C109078:lamivudine, zidovudine drug combination; D019259:Lamivudine; D015215:Zidovudine; D019888:Nelfinavir